Heidelberg Pharma AG (XTER:HPHA)
€ 2.66 -0.06 (-2.21%) Market Cap: 123.97 Mil Enterprise Value: 91.49 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 60/100

Q2 2020 Heidelberg Pharma AG Earnings Call Transcript

Jul 09, 2020 / 01:00PM GMT
Release Date Price: €4.52 (-2.80%)
Operator

Good afternoon, and welcome to the Heidelberg Pharma Half-Yearly Financial Report 2020. The call will be hosted by Dr. Jan Schmidt-Brand, CEO and CFO of Heidelberg Pharma AG. My name is Anika, and I'll be your coordinator for today's conference. (Operator Instructions)

I'm now handing you over to your host, Dr. Jan Schmidt-Brand, CEO and CFO, to begin today's conference. Please go ahead.

Jan Schmidt;Brand
Heidelberg Pharma AG - CEO, CFO & Member of the Executive Management Board

Thank you, Anika. Hello, ladies and gentlemen. Welcome to the Heidelberg Pharma Press, Analysts and Investors Conference Call to discuss our financial results for the first half 2020 and to provide a business update. My name is Jan Schmidt-Brand, I'm CEO and CFO of the company. Joining me on the call today are my colleagues, Professor Andreas Pahl, Chief Scientific Officer; and Katja Arnold, our Investor Relations Consultant.

Please note that this presentation is available for download on the Heidelberg Pharma website. This conference call is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot